OrthoPediatrics filed to raise up to US $75MM in an initial public offering. The company plans to list on the NASDAQ under the symbol KIDS. Pricing terms are not disclosed.
OrthoPediatrics was founded in 2006 and logged $31MM in revenue for 2015. The company has developed and received regulatory clearance for 17 surgical systems for trauma, long bone deformity and correction, scoliosis and sports-medicine, focused on pediatric patients.
Within 2016, OrthoPediatrics announced partnerships with SpineGuard for distribution of PediGuard probes, as a complement to its RESPONSE™ Spine System for pediatric spinal deformity cases, and with Robert Reid for distribution of RESPONSE in Japan.
OrthoPediatrics filed to raise up to US $75MM in an initial public offering. The company plans to list on the NASDAQ under the symbol KIDS. Pricing terms are not disclosed.
OrthoPediatrics was founded in 2006 and logged $31MM in revenue for 2015. The company has developed and received regulatory clearance for 17 surgical systems for...
OrthoPediatrics filed to raise up to US $75MM in an initial public offering. The company plans to list on the NASDAQ under the symbol KIDS. Pricing terms are not disclosed.
OrthoPediatrics was founded in 2006 and logged $31MM in revenue for 2015. The company has developed and received regulatory clearance for 17 surgical systems for trauma, long bone deformity and correction, scoliosis and sports-medicine, focused on pediatric patients.
Within 2016, OrthoPediatrics announced partnerships with SpineGuard for distribution of PediGuard probes, as a complement to its RESPONSE™ Spine System for pediatric spinal deformity cases, and with Robert Reid for distribution of RESPONSE in Japan.
Copy to clipboard 
